Alto Neuroscience, Correlations
ANRO Stock | 4.28 0.05 1.15% |
The current 90-days correlation between Alto Neuroscience, and Allient is 0.27 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Alto Neuroscience, Correlation With Market
Weak diversification
The correlation between Alto Neuroscience, and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and DJI in the same portfolio, assuming nothing else is changed.
Alto |
Moving together with Alto Stock
0.62 | VALN | Valneva SE ADR | PairCorr |
0.66 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.77 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.81 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.86 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.76 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.71 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.63 | BIAFW | BioAffinity Technologies | PairCorr |
0.62 | MREO | Mereo BioPharma Group | PairCorr |
0.82 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.83 | PEPG | PepGen | PairCorr |
0.61 | RGNX | Regenxbio | PairCorr |
0.74 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.67 | AMGN | Amgen Inc | PairCorr |
Moving against Alto Stock
0.77 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.76 | GILD | Gilead Sciences | PairCorr |
0.68 | NAMS | NewAmsterdam Pharma | PairCorr |
0.67 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.59 | PHVS | Pharvaris BV | PairCorr |
0.56 | LPTX | Leap Therapeutics | PairCorr |
0.52 | LPCN | Lipocine | PairCorr |
0.38 | PLRX | Pliant Therapeutics | PairCorr |
0.89 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.82 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.8 | VREX | Varex Imaging Corp | PairCorr |
0.79 | AVTE | Aerovate Therapeutics | PairCorr |
0.69 | CDXS | Codexis | PairCorr |
0.63 | AGIO | Agios Pharm | PairCorr |
0.45 | SYRE | Spyre Therapeutics Symbol Change | PairCorr |
0.4 | ANTX | AN2 Therapeutics | PairCorr |
Related Correlations Analysis
0.56 | 0.82 | 0.94 | 0.0 | -0.9 | SAIA | ||
0.56 | 0.81 | 0.66 | 0.0 | -0.67 | ALNT | ||
0.82 | 0.81 | 0.9 | 0.0 | -0.88 | LIND | ||
0.94 | 0.66 | 0.9 | 0.0 | -0.89 | ODFL | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | FIGI | ||
-0.9 | -0.67 | -0.88 | -0.89 | 0.0 | BCE | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alto Stock performing well and Alto Neuroscience, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alto Neuroscience,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SAIA | 2.20 | 0.43 | 0.24 | 0.33 | 1.91 | 5.11 | 17.45 | |||
ALNT | 2.15 | 0.26 | 0.07 | 0.98 | 2.37 | 5.25 | 11.31 | |||
LIND | 2.45 | 0.03 | 0.07 | 0.13 | 2.32 | 4.63 | 29.57 | |||
ODFL | 1.55 | 0.02 | 0.06 | 0.13 | 2.11 | 2.68 | 14.71 | |||
FIGI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
BCE | 0.88 | (0.38) | 0.00 | (3.44) | 0.00 | 1.53 | 12.47 |
Alto Neuroscience, Corporate Management
Melissa Berman | Vice Accounting | Profile | |
Michael MBA | Chief Officer | Profile | |
Jason Hoffman | Vice Resources | Profile | |
Erin JD | General Officer | Profile |